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In this issue of Immunity, Olson et al. (2013) demonstrate that circulating CD8+ memory T cells with an
effector-like phenotype, previously thought to be mostly senescent, provide robust protection from a
secondary pathogen challenge despite their poor secondary proliferative response.During the process of activation and dif-
ferentiation in response to infectious
pathogens, some CD8+ T cells acquire
the ability to persist into the memory
pool. Because these memory cells are
the key component of protective immu-
nity to intracellular pathogens, unraveling
the mechanisms behind their differentia-
tion and function has been of intense
interest. It is now appreciated that CD8+
memory T cells are heterogeneous, and
distinct subsets can be distinguished on
the basis of their trafficking patterns,
effector functions, tissue residence,
longevity, and proliferative capacity (Mu-
eller et al., 2013). Less is known about
the relative role of these subsets in pro-
moting protective immunity to a second
pathogen exposure.
Initially, effector and central memory
CD8+ T cells were defined on the basis
of unique expression of trafficking recep-
tors and the tendency to migrate to either
peripheral tissues or secondary lymphoid
organs (SLOs). However, although central
memory CD8+ T cells maintain the highest
proliferative capacity upon secondary
challenge, the relative protective capacity
of each subset seems to depend on the
nature of the secondary challenge (Bach-
mann et al., 2005a, 2005b; Wherry et al.,
2003). More recently, effector cytotoxicT lymphocytes (CTL) were segregated
into two subsets: those that expressed
high amounts of interleukin-7Ra (IL-7Ra)
and preferentially populated the long-
lived memory pool and those that ex-
pressed high amounts of the differentia-
tion marker KLRG1 and failed to establish
long-lived memory. KLRG1+ CTL were
demonstrated to largely consist of termi-
nally differentiated effector cells with little
proliferative capacity and poor long-term
survival (Joshi et al., 2007). Whereas their
numbers decline relative to other memory
CTL subsets during memory mainte-
nance, effector-phenotype memory CTL
that are at least in part phenotypically
distinct from conventionally defined
effector memory cells can persist for
several months after primary infection
(Mitchell et al., 2010). Nevertheless, the
long-held assumption has been that
these cells are senescent and unlikely to
play an important role in protection.
In this issue of Immunity, Olson et al.
(2013) employ a system of adoptive
transfer and heterologous immunization
to explore the per cell ability of effector-
phenotype memory CTL to mediate
protective immunity. In contrast to their
poor proliferative capacity, effector-
phenotype memory CTL displayed supe-
rior protective capacity to systemicsecondary challenges with either Listeria
monocytogenes or vaccinia virus.
Furthermore, these cells were greatly
enriched in the secondary memory CTL
pool following boosting without exhibit-
ing any loss in their protective capacity.
Because protective capacity and pro-
liferative capacity are clearly unlinked in
this system, what accounts for the en-
hanced protective capacity of effector-
phenotype memory CTL? One explana-
tion might be their enhanced cytolytic
function. Effector-phenotype memory
CTL expressed higher amounts of Gran-
zyme B than other memory subsets and
depended on Perforin for their protective
function, leading the authors to conclude
that their protective activity was depen-
dent on their direct cytolytic function.
Another contributing factor is likely to be
their localization. In support of this, the
authors show that within the spleen,
effector-phenotype memory CTL reside
primarily in the red pulp and accounted
for the majority of memory CTL in circu-
lation, whereas central memory CD8+
T cells reside primarily in the white pulp.
Because the red pulp is a primary point
of contact between CD8+ memory T cells
and blood-borne Listeria or Listeria-
infected macrophages (Baje´noff et al.,
2010), the ability of effector-phenotype
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Figure 1. Effector-Phenotype CD8+ Memory
T Cells Play a Direct Role in Mediating
Protection from Blood-Borne Listeria
monocytogenes
Olson et al. (2013) demonstrate that circulating
effector-phenotype memory T cells (Teff) mediate
clearance of blood-borne Listeria monocytogenes
via direct cytolysis of infected cells. Their relation-
ship to effector memory cells (Tem) and resident
memory T cells (Trm) during the secondary
response, or whether they migrate rapidly to tissue
sites of infection, is not known. Tem participate in
the clearance of blood-borne Listeria monocyto-
genes directly and, in addition, are recruited to tis-
sue sites of infection by activated Trm, mediating
clearance of pathogens at these sites. Trm do not
circulate but reside in previously infected tissues,
mediating rapid trafficking of circulating memory
cells into the tissue following secondary pathogen
exposure.
Immunity
Previewsmemory CTLs to colocalize with the
pathogen is likely a key factor in their
protective function.
It is not clear what role this subset of
memory T cells might play at sites of likely
pathogen exposure, such as mucosal
surfaces and tissues in the respiratory
tract, reproductive tract, or gut. Noncircu-
lating tissue-resident memory CTL persist
long-term in these tissues, and a recent
study described their role in orchestrating
chemokine-mediated rapid migration ofcirculating memory CTL to tissue sites of
infection (Schenkel et al., 2013). It will be
important to determine whether this rep-
resents recruitment of effector-pheno-
type CTLs, more conventional circulating
effector memory cells (KLRG1lo, IL7Rahi)
or both. Regardless, it is apparent that
reference to ‘‘effector memory’’ CD8+
T cells will need to be further refined to
reflect the complex and functionally
diverse nature of these subsets.
These findings together suggest
unique but coordinated roles for tissue-
resident, circulating, and SLO-homing
CD8+ memory T cells in providing protec-
tion and repopulating the memory pool
following secondary pathogen exposure
(Figure 1). It is likely that the protective
capacity of individual subsets will vary
depending on the nature of the pathogen
challenge, a concept supported by the
finding that protection from lymphocytic
choriomeningitis virus (LCMV) challenge,
which readily accesses secondary
lymphoid tissues, is most effectively
mediated by central memory CD8+
T cells (Bachmann et al., 2005a; Wherry
et al., 2003).
It is likely that as understanding of the
role of memory T cell subsets in mediating
protection increases, parameters for
optimal protection from individual patho-
gens will need to be defined as well.
Whereas past efforts in studying memory
T cell biology have focused onwhat is be-
ing remembered (e.g., the establishment
of long-lived memory within SLOs), cur-
rent approaches have highlighted the
need to focus on the ability of CD8+ mem-
ory T cells to remember the where (e.g.,
the establishment of resident memory at
tissue sites of infection) and when (e.g.,
the development of relatively short-lived
but highly protective effector-phenotype
memory T cells) of pathogen exposure.
One intriguing hypothesis is that memory
T cell differentiation is designed to most
effectively counter secondary pathogen
exposures in the weeks and months
following primary exposure, a period of
time in which secondary pathogen expo-
sure within a community might be most
likely.Immunity 3The development of vaccines and
immunotherapies has relied largely on
generating large numbers of antigen-spe-
cific CD8+ memory T cells. For example,
current HIV vaccination efforts have
used vector-based vaccines and prime-
boost strategies to enhance the numbers
of circulating memory T cells and anti-
bodies (Benmira et al., 2010). The current
study supports a growing body of litera-
ture highlighting that the make-up and
localization of the CD8+ memory popula-
tion might be a better predictor of protec-
tive efficacy in a pathogen-specific
manner. Although the authors employ a
highly useful reductionist approach to
highlight the relative protective efficacy
of individual subsets, it is likely that these
subsets work in coordination in providing
protection. Future studies will need to
further define the functional relationship
between tissue-resident, circulating, and
SLO-homing CD8+memory T cell subsets
in promoting protective immunity.REFERENCES
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